The Food and Drug Administration is mulling over conducting its own evaluation of the levels of DNA in COVID-19 vaccines, an FDA official has disclosed.
“I’ll say that that is something that’s being discussed,” Dr. Tracy Hoeg, a senior adviser to the FDA’s commissioner, told members of the Centers for Disease Control and Prevention’s vaccine advisory panel on Sept. 19.
Before the panel’s members unanimously recommended during the meeting that the CDC roll back COVID-19 vaccine recommendations, a number expressed concerns about growing evidence of higher-than-allowed levels of DNA in the vaccines, the spread of the vaccine beyond the injection site, and the long-term persistence of messenger ribonucleic acid (mRNA)—a key part of the Pfizer-BioNTech and Moderna shots….